Prevalence of Preeclampsia and Eclampsia in Iran: An Updated Systematic Review and Meta-Analysis.

IF 16.4 1区化学 Q1 CHEMISTRY, MULTIDISCIPLINARY

Accounts of Chemical Research Pub Date : 2024-09-04 eCollection Date: 2024-09-01 DOI:10.4103/ijnmr.ijnmr_299_23

Sedigheh Abdollahpour, Talat Khadivzadeh, Mahla Shafeei, Mahdieh Arian

{"title":"Prevalence of Preeclampsia and Eclampsia in Iran: An Updated Systematic Review and Meta-Analysis.","authors":"Sedigheh Abdollahpour, Talat Khadivzadeh, Mahla Shafeei, Mahdieh Arian","doi":"10.4103/ijnmr.ijnmr_299_23","DOIUrl":null,"url":null,"abstract":"Background: Preeclampsia is a major contributor to maternal morbidity and mortality. A previous systematic review was carried out in Iran in 2014. Due to the importance of this issue, a current evaluation is necessary after ten years. This research was performed to determine the prevalence of preeclampsia and eclampsia in Iran.Materials and methods: Adhering to the PRISMA guideline, we searched English databases including Web of Science, PubMed, Scopus, and Persian databases including SID, Magiran, and IranMedex on August 20, 2023, to identify studies reporting the prevalence of preeclampsia or eclampsia in Iran. Employing a focused term strategy and eligibility criteria, we ultimately included 55 studies in this review. After conducting a thorough evaluation, the CMAV3 software was utilized to analyze the data using the random effects model and calculate pooled results.Results: The overall prevalence of preeclampsia among Iranian mothers was 5.3%, while eclampsia accounted for 0.1% of live births. Notably, preeclampsia rates have risen since 2015, whereas eclampsia rates have declined over time. Single-variable meta-regression results indicated a negative correlation between age and preeclampsia.Conclusions: Preeclampsia is increasing among Iranian mothers, requiring an investigation into its risk factors, including maternal age, and consequently, high-risk pregnancies. Conversely, the decreasing occurrence of eclampsia indicates an enhancement in the quality of care following a preeclampsia diagnosis.","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2024-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11521136/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/ijnmr.ijnmr_299_23","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/9/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Preeclampsia is a major contributor to maternal morbidity and mortality. A previous systematic review was carried out in Iran in 2014. Due to the importance of this issue, a current evaluation is necessary after ten years. This research was performed to determine the prevalence of preeclampsia and eclampsia in Iran.

Materials and methods: Adhering to the PRISMA guideline, we searched English databases including Web of Science, PubMed, Scopus, and Persian databases including SID, Magiran, and IranMedex on August 20, 2023, to identify studies reporting the prevalence of preeclampsia or eclampsia in Iran. Employing a focused term strategy and eligibility criteria, we ultimately included 55 studies in this review. After conducting a thorough evaluation, the CMAV3 software was utilized to analyze the data using the random effects model and calculate pooled results.

Results: The overall prevalence of preeclampsia among Iranian mothers was 5.3%, while eclampsia accounted for 0.1% of live births. Notably, preeclampsia rates have risen since 2015, whereas eclampsia rates have declined over time. Single-variable meta-regression results indicated a negative correlation between age and preeclampsia.

Conclusions: Preeclampsia is increasing among Iranian mothers, requiring an investigation into its risk factors, including maternal age, and consequently, high-risk pregnancies. Conversely, the decreasing occurrence of eclampsia indicates an enhancement in the quality of care following a preeclampsia diagnosis.

查看原文本刊更多论文

伊朗子痫前期和子痫的患病率：最新的系统回顾和元分析。

背景：子痫前期是导致孕产妇发病和死亡的主要因素。伊朗曾于 2014 年进行过一次系统性回顾。鉴于这一问题的重要性，有必要在十年后进行一次最新评估。本研究旨在确定伊朗子痫前期和子痫的发病率：根据 PRISMA 指南，我们于 2023 年 8 月 20 日检索了英文数据库（包括 Web of Science、PubMed、Scopus）和波斯文数据库（包括 SID、Magiran 和 IranMedex），以确定报告伊朗子痫前期或子痫患病率的研究。我们采用了聚焦术语策略和资格标准，最终将 55 项研究纳入了本综述。在进行全面评估后，我们利用 CMAV3 软件使用随机效应模型对数据进行了分析，并计算了汇总结果：结果：伊朗母亲的子痫前期总发病率为 5.3%，而子痫占活产婴儿的 0.1%。值得注意的是，子痫前期发病率自2015年以来有所上升，而子痫发病率则随着时间的推移有所下降。单变量元回归结果表明，年龄与子痫前期呈负相关：结论：子痫前期在伊朗母亲中的发病率正在上升，需要对其风险因素进行调查，包括产妇年龄，以及高危妊娠。相反，子痫发生率的下降表明，子痫前期诊断后的护理质量有所提高。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Accounts of Chemical Research 化学-化学综合

CiteScore

31.40

自引率

1.10%

发文量

312

审稿时长

2 months

期刊介绍： Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance. Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.